Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression

Current Therapeutic Research

Volumn 56, Issue 6, 1995, Pages 556-567

  Skaer, Tracy L ^a,b   Sclar, David A ^a,c   Robison, Linda M ^a   Galin, Richard S ^b,d   Legg, Randall F ^c   Nemic, Neil L ^c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Pullman Memorial Hospital   (United States)

^c Qual Med Health Plan of Washington Inc   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; DEPRESSION; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH SERVICE; HUMAN; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PRESCRIPTION; PREVALENCE; PSYCHIATRIST;

EID: 0029040591     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0011-393X(95)85047-3     Document Type: Article

References (23)

1. Service utilization and social morbidity associated with depressive symptoms in the community
2. The economic impact of depression in a workplace
3. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment
4. How can care for depression become more cost-effective
5. Debits and credits in the management of depression
6. The economic burden of depression in 1990
7. Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness
8. Sertraline: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder
9. Fluoxetine: A five-year review
10. Comparative efficacy of antidepressants
11. The pharmacologic treatment of depression
12. Evolutionary trends in the pharmacotherapeutic management of depression
13. Contemporary management of depression
14. Striking a balance between safety and efficacy: Experience with the SSRI sertraline
15. Dosing strategies for antidepressant agents
16. Antidepressant treatment and side effect considerations
17. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants
18. Current status of antidepressants: Clinical pharmacology and therapy
19. Managing tricyclic antidepressant overdose
20. Agency for Health Care Policy and Research
21. Long-term treatment of depression
22. Quality of life: Experience with sertraline
23. Applying pharmacoeconomic and quality-of-life measures to the formulary management process